Multiple sclerosis / Richard Spilsbury.
Multiple sclerosis, a progressive autoimmune disorder that affects the central nervous system, usually develops between the ages of twenty and fifty. This guide to multiple sclerosis describes the difference between the four types of the disease and how sufferers can manage their symptoms through medications such as corticosteroids. Though scientists are unsure what causes MS or how to prevent it from flaring up, readers will learn about new research into the genetic factors of the disease that could lead to new gene therapy treatments.
Record details
- ISBN: 9781508182832
- Physical Description: 48 pages : colour, illustration, 30 cm.
- Publisher: New York, NY : Rosen Central, 2019.
Content descriptions
General Note: | Includes index. |
Formatted Contents Note: | What is Multiple Sclerosis? -- What causes Multiple Sclerosis -- Treating Multiple Sclerosis -- Living with Multiple Sclerosis -- Multiple Sclerosis and Gene Therapy -- Glossary -- For Further Reading -- Index. |
Search for related items by subject
Subject: | Multiple sclerosis > Juvenile literature. |
Search for related items by series
Available copies
- 1 of 1 copy available at College of the Rockies.
Holds
- 0 current holds with 1 total copy.
Show Only Available Copies
Location | Call Number / Copy Notes | Barcode | Shelving Location | Circulation Modifier | Holdable? | Status | Due Date | Courses |
---|---|---|---|---|---|---|---|---|
Cranbrook Campus | RC 377 .S646 2019 (Text) | 31111000147130 | CRANBROOK | Volume hold | Available | - |
Summary:
Multiple sclerosis, a progressive autoimmune disorder that affects the central nervous system, usually develops between the ages of twenty and fifty. This guide to multiple sclerosis describes the difference between the four types of the disease and how sufferers can manage their symptoms through medications such as corticosteroids. Though scientists are unsure what causes MS or how to prevent it from flaring up, readers will learn about new research into the genetic factors of the disease that could lead to new gene therapy treatments.